Results
On average, patients were 59 years old and Figure 2 presents the breakdown of medications prescribed.
Patients' reported reasons for switching and/or non-adherence included: increased pain/swelling (34%), feeling the medication is not working and/or continual progression of symptoms (35%) and adverse reaction to medication such as itching (11%) and GI complications (11%) ( Figure  3 ).
Of the physicians who recommended switching, reasons for switching their patients' medications included potential toxicities associated with drugs (46%) and observed disease progression (34%) (Figure 4 ).
Methods
We extracted 300 patient records that were identified for people diagnosed with RA from a unique database of physician-patient interactions: RealHealthData (http://www.realhealthdata.com/). RealHealthData works with medical transcription companies across the country to build a database of detailed narrative medical records, providing a unique perspective on patient conditions and physician interaction. (Figure 1 ). In order to be included in the database, patients needed to be at least 18 years of age, diagnosed with Rheumatoid Arthritis and had an office visit with at least one physician in the past 12 months.
Using Atlas.ti and Excel, we analyzed these patient records to evaluate how often the recommended assessments of disease activity was documented by physicians during office visits.
Background
High rates of non-adherence or switching of medications for patients diagnosed with Rheumatoid Arthritis is not uncommon.¹ , ² "Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events."² Observational studies indicate that some patients are non-adherent or switch medications due to toxicity and tolerability; however, given the changing healthcare environment, especially in the United States, it's not just the effectiveness of the drug but also the cost of the medications that may be an inhibiting factor as well.³ ,4
The ultimate goals in managing Rheumatoid Arthritis (RA) are preventing or controlling joint damage. A large part of controlling joint damage is finding and staying on appropriate medication; therefore, the objective of this study was to examine when, why and how patients stopped or switched their medication. In addition, we analyzed physicians' noted reasons for switching.
Conclusions
It is critical to better understand patients' and physicians' reasons for switching medication for chronic disease like RA. The more we know about reasons for behavior, the more we can actively plan and organize research, development and outreach that is patient-centric and clinically meaningful. Our results demonstrate that using physician-patient interaction data can add tremendous value to outcomes researchers and healthcare decision makers. Sci. 1173 Sci. , 837-846 (2009 .
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Direct Quotes
A unique feature of the data from RealHealthData is the ability to catch a glimpse of the physician-patient interaction the same day it happens -without having to survey the patients or physicians. Data is recorded as it happens without having to be concerned about recall or bias. In this section, we present excerpts from the notes so you have a better understanding of the narrative provided in the medical records. 
